Literature DB >> 25868141

Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.

Severin O Gose1, Olusegun O Soge, James L Beebe, Duylinh Nguyen, Juliet E Stoltey, Heidi M Bauer.   

Abstract

We report a treatment failure to azithromycin 2.0 g caused by a urethral Neisseria gonorrhoeae isolate with high-level azithromycin resistance in California. This report describes the epidemiological case investigation and phenotypic and genetic characterization of the treatment failure isolate.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25868141      PMCID： PMC5972538          DOI： 10.1097/OLQ.0000000000000265

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  16 in total

1.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae.

Authors:  Patricia G Galarza; Raquel Abad; Liliana Fernández Canigia; Luis Buscemi; Irene Pagano; Claudia Oviedo; Julio A Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2010-02-01       Impact factor: 5.191

3.  Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates.

Authors:  V A Luna; S Cousin; W L Whittington; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Authors:  Robert D Kirkcaldy; Olusegun Soge; John R Papp; Edward W Hook; Carlos del Rio; Grace Kubin; Hillard S Weinstock
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

5.  Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina.

Authors:  Patricia G Galarza; Belén Alcalá; Celia Salcedo; Liliana Fernández Canigia; Luis Buscemi; Irene Pagano; Claudia Oviedo; Julio A Vázquez
Journal:  Sex Transm Dis       Date:  2009-12       Impact factor: 2.830

6.  The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Authors:  Robert D Kirkcaldy; Hillard S Weinstock; Page C Moore; Susan S Philip; Harold C Wiesenfeld; John R Papp; Peter R Kerndt; Shacondra Johnson; Khalil G Ghanem; Edward W Hook
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

7.  Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada.

Authors:  Vanessa G Allen; Christine Seah; Irene Martin; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

8.  Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland.

Authors:  Helen M Palmer; Hugh Young; Andrew Winter; Jayshree Dave
Journal:  J Antimicrob Chemother       Date:  2008-06-13       Impact factor: 5.790

Review 9.  The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2013-12       Impact factor: 3.519

10.  Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.

Authors:  Severin Gose; Duylinh Nguyen; Daniella Lowenberg; Michael Samuel; Heidi Bauer; Mark Pandori
Journal:  BMC Infect Dis       Date:  2013-12-04       Impact factor: 3.090
View more
  13 in total

1.  Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin.

Authors:  Ellen N Kersh; Vanessa Allen; Eric Ransom; Matthew Schmerer; Sancta Cyr; Kim Workowski; Hillard Weinstock; Jean Patel; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.

Authors:  L Ryan; D Golparian; N Fennelly; L Rose; P Walsh; B Lawlor; M Mac Aogáin; M Unemo; B Crowley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-07       Impact factor: 3.267

3.  Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.

Authors:  Matthew W Schmerer; A Jeanine Abrams; Sandra Seby; Jesse C Thomas; John Cartee; Sean Lucking; Eshaw Vidyaprakash; Cau D Pham; Samera Sharpe; Kevin Pettus; Sancta B St Cyr; Elizabeth A Torrone; Ellen N Kersh; Kim M Gernert
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

4.  Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Authors:  Carolien M Wind; Maarten F Schim van der Loeff; Alje P van Dam; Henry Jc de Vries; Jannie J van der Helm
Journal:  Euro Surveill       Date:  2017-01-05

Review 5.  Confronting Rising STIs in the Era of PrEP and Treatment as Prevention.

Authors:  Meena S Ramchandani; Matthew R Golden
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

6.  Evaluation of the Microbiological Efficacy of a Single 2-Gram Dose of Extended-Release Azithromycin by Population Pharmacokinetics and Simulation in Japanese Patients with Gonococcal Urethritis.

Authors:  Midori Soda; Shin Ito; Naoki Matsumaru; Sakiko Nakamura; Izumi Nagase; Hikari Takahashi; Yuta Ohno; Mitsuru Yasuda; Miho Yamamoto; Katsura Tsukamoto; Yoshinori Itoh; Takashi Deguchi; Kiyoyuki Kitaichi
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

7.  Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012-2016.

Authors:  Lindley A Barbee; Olusegun O Soge; David A Katz; Julia C Dombrowski; King K Holmes; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

8.  In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.

Authors:  Olusegun O Soge; Stephen J Salipante; David No; Erin Duffy; Marilyn C Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

9.  Study on montmorillonite-chlorhexidine acetate-terbinafine hydrochloride intercalation composites as drug release systems.

Authors:  Baohong Sun; Ming Zhang; Ninglin Zhou; Xiaohong Chu; Ping Yuan; Cheng Chi; Fan Wu; Jian Shen
Journal:  RSC Adv       Date:  2018-06-12       Impact factor: 3.361

Review 10.  Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.

Authors:  Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.